Global Urinalysis Equipment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Instruments [Biochemical Urine Analyzer [Automated Biochemical Analyzers and Semi-Automated Biochemical Analyzers], Automated Urine Sediment Analyzers [Microscopic Urine Analyzers and Flow-Cytometric Urine Analyzers]], Dipsticks, Reagents, and Disposables

By Application;

Urinary Tract Infections (UTI), Diabetes, Kidney Diseases, Hypertension, Liver Diseases, and Others

By End Use;

Hospitals, Clinical Laboratories, Home Healthcare, Research & Academics, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn274182425 Published Date: May, 2025 Updated Date: June, 2025

Urinalysis Equipment Market Overview

Urinalysis Equipment Market (USD Million)

Urinalysis Equipment Market was valued at USD 2,365.00 million in the year 2024. The size of this market is expected to increase to USD 3,283.67 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.8%.


Global Urinalysis Equipment Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 4.8 %


Study Period2025 - 2031
Base Year2024
CAGR (%)4.8 %
Market Size (2024)USD 2,365.00 Million
Market Size (2031)USD 3,283.67 Million
Market ConcentrationHigh
Report Pages301
2,365.00
2024
3,283.67
2031

Major Players

  • Siemens Healthineers
  • Roche Diagnostics
  • Beckman Coulter
  • Sysmex Corporation
  • Abbott Laboratories
  • BD (Becton, Dickinson and Company)
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • ARKRAY, Inc
  • URIT Medical Electronic Co., Ltd

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Urinalysis Equipment Market

Fragmented - Highly competitive market without dominant players


The Urinalysis Equipment Market is steadily expanding as healthcare systems prioritize non-invasive diagnostics for early disease detection. Urinalysis is essential for identifying conditions like diabetes, kidney issues, and urinary tract infections, pushing adoption of automated equipment across medical settings.

Automation Driving Accuracy and Efficiency
Continual improvements in urinalysis automation are streamlining diagnostic workflows. Modern systems now combine chemical, microscopic, and flow-based tests, which are adopted by more than 35% of facilities seeking faster and more precise diagnostics. These advanced platforms help healthcare professionals deliver timely and consistent results, making them increasingly preferred in high-volume clinical environments.

Workflow Enhancement Through System Integration
Healthcare institutions are now integrating urinalysis equipment with digital tools such as EHRs and laboratory software. More than 50% of providers opt for systems that facilitate automated data sharing and reporting, minimizing errors and enhancing care coordination. Such connectivity features are becoming critical in purchasing decisions, particularly in multi-departmental clinical setups.

Policy Backing and Diagnostic Awareness
Governments and health organizations are promoting routine urinalysis testing through educational initiatives and policy incentives. Awareness campaigns have grown by 45%, increasing public engagement in regular diagnostic checks. This has improved detection rates of asymptomatic diseases and expanded access to modern urinalysis technologies, reinforcing the market’s upward trajectory.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Application
    3. Market Snapshot, By End Use
    4. Market Snapshot, By Region
  4. Global Urinalysis Equipment Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising geriatric population requiring frequent testing

        2. Growing focus on preventive healthcare and early diagnosis

        3. Technological advancements in automated and AI-enabled analyzers

      2. Restraints
        1. High cost of advanced urinalysis equipment

        2. Stringent regulatory and compliance requirements

        3. Shortage of skilled professionals to operate automated systems

        4. Availability of low-cost refurbished equipment

      3. Opportunities
        1. Integration of smartphone-based and lab-on-a-chip technologies

        2. Rising adoption of point-of-care and portable testing devices

        3. Advancements in automated, AI-enabled, and microfluidic technologies

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Urinalysis Equipment Market, By Product, 2021 - 2031 (USD Million)
      1. Instruments
        1. Biochemical Urine Analyzer
          1. Automated Biochemical Analyzers
          2. Semi-automated Biochemical Analyzers
        2. Automated Urine Sediment Analyzers
          1. Microscopic urine analyzers
          2. Flow-cytometric urine analyzers
      2. Consumables
        1. Dipsticks
        2. Reagents
        3. Disposables
    2. Global Urinalysis Equipment Market, By Application, 2021 - 2031 (USD Million)
      1. Urinary Tract Infections (UTI)
      2. Diabetes
      3. Kidney Diseases
      4. Hypertension
      5. Liver Diseases
      6. Others
    3. Global Urinalysis Equipment Market, By End Use, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Clinical Laboratories
      3. Home healthcare
      4. Research and Academics
      5. Others
    4. Global Urinalysis Equipment Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Siemens Healthineers
      2. Roche Diagnostics
      3. Beckman Coulter
      4. Sysmex Corporation
      5. Abbott Laboratories
      6. BD (Becton, Dickinson and Company)
      7. Thermo Fisher Scientific
      8. Bio-Rad Laboratories
      9. ARKRAY, Inc
      10. URIT Medical Electronic Co., Ltd
  7. Analyst Views
  8. Future Outlook of the Market